Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in the Registration Statement (Form S-3) and related Prospectus of Inozyme Pharma, Inc. for the registration of its debt securities, common stock, preferred stock, depositary shares, subscription rights, warrants and/or units and to the incorporation by reference therein of our report dated March 25, 2021, with respect to the consolidated financial statements of Inozyme Pharma, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2020, filed with the Securities and Exchange Commission.
| /s/ Ernst & Young LLP |
| Boston, Massachusetts |
| August 11, 2021 |
